Notícias Ocean Biomedical Inc - OCEA | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Ocean Biomedical Inc (OCEA)
Ocean Biomedical Inc (OCEA) Notícias

Ocean Biomedical Inc (OCEA)

0,09

0,0037

(4,29%)

Fechado 09 Março 5:00PM

Atrasado por 15 minutos

0,088

-0,002

(-2,22%)

Após o horário de negociação: 9:58PM

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Form 424B3 - Prospectus [Rule 424(b)(3)]

Ocean Biomedical, Inc. (NASDAQ: OCEA) Celebrates 95% Lung Cancer Tumor Reduction Results on World Lung Cancer Day

Form PRE 14A - Other preliminary proxy statements

Ocean Biomedical’s (NASDAQ: OCEA) mRNA-based Vaccine Candidate Generates Over 90% Killing of Malaria Parasites in Non-human Primates, Demonstrating Broad Potential for Ocean’s Program to Address Global and Emerging U.S. Malaria Challenges

Form EFFECT - Notice of Effectiveness

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Ocean Biomedical, Inc. Joins the Russell 2000® Index

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces U.S. Patent Issued for Bispecific Cancer Immunotherapy Treatment With Demonstrated Killing of Tumor Cells in Lung Cancer, Brain Cancer (Glioblastoma), and Metastatic Melanoma.

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Securities Registration Statement (s-1)

Ocean Biomedical (NASDAQ: OCEA) Extends Patent Rights for Breakthrough Idiopathic Pulmonary Fibrosis Discovery To Europe

Notice of Effectiveness (effect)

Ocean Biomedical (NASDAQ: OCEA) Announces Share Price Target Increase to $17.63 by Fundamental Research Corp. on Positive Results from Independent Study Showing Glioblastoma Tumor Suppression, Received Patents, and Recent Financing

Securities Registration Statement (s-1/a)

Small Company Offering and Sale of Securities Without Registration (d)

2
3
4
Próxima

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Ocean Biomedical

Manulife Multifactor Dev...

Invesco BulletShares 202...

Metro One Development (CE)

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições